speb/financial-data huggingface dataset:
RPRX balance_sheet (annual, 2024-12-31) — Receivables: 26956000.00
RPRX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 0.00
RPRX cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
RPRX cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
RPRX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -229651000.00
RPRX income_statement (annual, 2024-12-31) — Research And Development: 2000000.00
RPRX balance_sheet (annual, 2024-12-31) — Retained Earnings: 2845653000.00
RPRX cash_flow (annual, 2024-12-31) — Sale Of Investment: 118361000.00
RPRX income_statement (annual, 2024-12-31) — Selling General And Administration: 236671000.00
RPRX balance_sheet (annual, 2024-12-31) — Share Issued: 445985000.00
RPRX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
RPRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2344000.00
RPRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6946581000.00
RPRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 6946581000.00
RPRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
RPRX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
RPRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
RPRX balance_sheet (annual, 2024-12-31) — Total Assets: 18222715000.00
RPRX balance_sheet (annual, 2024-12-31) — Total Capitalization: 13561234000.00
RPRX balance_sheet (annual, 2024-12-31) — Total Debt: 7612426000.00
RPRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 10342366000.00
RPRX income_statement (annual, 2024-12-31) — Total Expenses: 971132000.00
RPRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 7880349000.00
RPRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 16420576000.00
RPRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 6626733000.00
RPRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1292444000.00
RPRX income_statement (annual, 2024-12-31) — Total Unusual Items: 188455000.00
RPRX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 188455000.00
RPRX balance_sheet (annual, 2024-12-31) — Treasury Stock: 2662000.00
RPRX balance_sheet (annual, 2024-12-31) — Working Capital: 548523000.00
RPRX income_statement (annual, 2024-12-31) — Write Off: 0.00
RPRX income_statement (quarterly, 2025-03-31) — +Operating Expense: 34065000.00
RPRX income_statement (quarterly, 2025-03-31) — +Total Revenue: 568247000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 37630000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 4210531000.00
RPRX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
RPRX balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 15392098000.00
RPRX income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 76758000.00
RPRX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 425590000.00
RPRX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.56
RPRX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 929026000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 106000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1087720000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1816379000.00
RPRX cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -95357000.00
RPRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -941299000.00
RPRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 503917000.00
RPRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 596076000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 10086000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -78841000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Interest Payable: -78841000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1108000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Payable: 10086000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -68755000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3171000.00
RPRX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -64476000.00
RPRX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 158694000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Common Stock: 106000.00
RPRX cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -95357000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6688647000.00
RPRX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -708781000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 19221000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Current Assets: 1843243000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Current Debt: 998605000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 998605000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1182852000.00
RPRX cash_flow (quarterly, 2025-03-31) — Depreciation: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 0.00
RPRX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 578000000.00
RPRX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.41
RPRX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 316107000.00
RPRX cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 13396000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 108796000.00
RPRX cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 36262000.00
RPRX income_statement (quarterly, 2025-03-31) — EBIT: 499694000.00
RPRX income_statement (quarterly, 2025-03-31) — EBITDA: 499694000.00
RPRX income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 6443000.00
RPRX cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -6443000.00
RPRX cash_flow (quarterly, 2025-03-31) — End Cash Position: 1087720000.00
RPRX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -941299000.00
RPRX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 596076000.00
RPRX cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -493612000.00
RPRX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -49159000.00
RPRX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 110705000.00
RPRX income_statement (quarterly, 2025-03-31) — Interest Expense: 65261000.00
RPRX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 65261000.00
RPRX income_statement (quarterly, 2025-03-31) — Interest Income: 11290000.00
RPRX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 11290000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Interest Payable: 19221000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 14306099000.00
RPRX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 503917000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 15392098000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 15728306000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 6618847000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 6618847000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 336208000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3100010000.00
RPRX income_statement (quarterly, 2025-03-31) — Minority Interests: -195084000.00
RPRX cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -708781000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Net Debt: 6529732000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Income: 239349000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 239349000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 434433000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 239349000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 239349000.00
RPRX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 434433000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 434433000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Interest Income: -53971000.00
RPRX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 517655000.00
RPRX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -53971000.00
RPRX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -137161000.00
RPRX cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -50000000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6688647000.00
RPRX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 548853000.00
RPRX income_statement (quarterly, 2025-03-31) — Normalized Income: 288508000.00
RPRX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 596076000.00
RPRX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -500055000.00
RPRX income_statement (quarterly, 2025-03-31) — Operating Income: 534182000.00
RPRX income_statement (quarterly, 2025-03-31) — Operating Revenue: 568247000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 425590000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3079000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 998605000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 18600000.00
RPRX income_statement (quarterly, 2025-03-31) — Other Gand A: 110705000.00
RPRX income_statement (quarterly, 2025-03-31) — Other Income Expense: -45778000.00
RPRX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 836122000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 36707000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 17900000.00
RPRX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -3062000.00
RPRX income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -127140000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 23785000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 728659000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Payables: 146426000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 165647000.00
RPRX income_statement (quarterly, 2025-03-31) — Pretax Income: 434433000.00
RPRX income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -127140000.00
RPRX cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -5484000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Receivables: 23785000.00
RPRX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -708781000.00
RPRX income_statement (quarterly, 2025-03-31) — Research And Development: 50500000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2480664000.00
RPRX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 523139000.00
RPRX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 110705000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Share Issued: 425590000.00
RPRX income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
RPRX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 515000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6688647000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6688647000.00
RPRX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RPRX income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
RPRX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
RPRX balance_sheet (quarterly, 2025-03-31) — Total Assets: 17608256000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 13307494000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Total Debt: 7617452000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 9788657000.00
RPRX income_statement (quarterly, 2025-03-31) — Total Expenses: 34065000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7819599000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15765013000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6636747000.00
RPRX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 534182000.00
RPRX income_statement (quarterly, 2025-03-31) — Total Unusual Items: -49159000.00
RPRX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -49159000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 2654000.00
RPRX cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 3281000.00
RPRX balance_sheet (quarterly, 2025-03-31) — Working Capital: 660391000.00
RPRX income_statement (quarterly, 2025-03-31) — Write Off: 0.00
RPRX income_statement (quarterly, 2025-06-30) — +Operating Expense: 368866000.00
RPRX income_statement (quarterly, 2025-06-30) — +Total Revenue: 578665000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 20209000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4127665000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 15516720000.00
RPRX income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 9697000.00
RPRX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 432288000.00
RPRX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
RPRX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1087720000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 107000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 631908000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1488046000.00
RPRX cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -93241000.00
RPRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -507814000.00
RPRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -311982000.00
RPRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 363984000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -6389000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 62566000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Interest Payable: 62566000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -2194000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -332000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Payable: -6389000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 56177000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -3958000.00
RPRX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 49693000.00
RPRX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -455812000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 107000.00
RPRX cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -93241000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6347910000.00
RPRX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -291572000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 85609000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 1520241000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Current Debt: 999436000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 999436000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1206526000.00
RPRX cash_flow (quarterly, 2025-06-30) — Depreciation: 1379000.00
RPRX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1379000.00
RPRX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1379000.00
RPRX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 562000000.00
RPRX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.05
RPRX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 39873000.00
RPRX cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 0.00
RPRX balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 98197000.00
RPRX cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 62988000.00
RPRX income_statement (quarterly, 2025-06-30) — EBIT: 159303000.00
RPRX income_statement (quarterly, 2025-06-30) — EBITDA: 160682000.00
RPRX income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 2693000.00
RPRX cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -2693000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 467143000.00
RPRX cash_flow (quarterly, 2025-06-30) — End Cash Position: 631908000.00
RPRX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -507814000.00
RPRX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 363984000.00
RPRX cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -486164000.00
RPRX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -59973000.00
RPRX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 179769000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Goodwill: 924634000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 924634000.00
RPRX income_statement (quarterly, 2025-06-30) — Interest Expense: 68668000.00
RPRX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 68668000.00
RPRX income_statement (quarterly, 2025-06-30) — Interest Income: 8327000.00
RPRX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 8327000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Interest Payable: 85609000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 14350409000.00
RPRX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -311982000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 15516720000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 15792634000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 7003063000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7003063000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 275914000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Minority Interest: 3155030000.00
RPRX income_statement (quarterly, 2025-06-30) — Minority Interests: -60459000.00
RPRX cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -74190000.00
RPRX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -291572000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Net Debt: 7370591000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Income: 30176000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 30176000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 90635000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 30176000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 30176000.00
RPRX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 89635000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 90635000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Interest Income: -60341000.00
RPRX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -73234000.00
RPRX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -60341000.00
RPRX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -123001000.00
RPRX cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -227546000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 5423276000.00
RPRX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 220655000.00
RPRX income_statement (quarterly, 2025-06-30) — Normalized Income: 90149000.00
RPRX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 363984000.00
RPRX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -488857000.00
RPRX income_statement (quarterly, 2025-06-30) — Operating Income: 209799000.00
RPRX income_statement (quarterly, 2025-06-30) — Operating Revenue: 578665000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 432288000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 4452000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 3075000.00
RPRX income_statement (quarterly, 2025-06-30) — Other Gand A: 179769000.00
RPRX income_statement (quarterly, 2025-06-30) — Other Income Expense: -58823000.00
RPRX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 736049000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 85491000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 143328000.00
RPRX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1543000.00
RPRX income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -111403000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 27743000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 856138000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Payables: 118406000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 204015000.00
RPRX income_statement (quarterly, 2025-06-30) — Pretax Income: 90635000.00
RPRX cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -111403000.00
RPRX cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -74190000.00
RPRX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -76114000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Receivables: 27743000.00
RPRX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1379000.00
RPRX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -291572000.00
RPRX income_statement (quarterly, 2025-06-30) — Research And Development: 300500000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2222750000.00
RPRX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 2880000.00
RPRX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 179769000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 432288000.00
RPRX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 90769000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6347910000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 5423276000.00
RPRX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
RPRX income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
RPRX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
RPRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 18323000000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 13350973000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 8002499000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 9502940000.00
RPRX income_statement (quarterly, 2025-06-30) — Total Expenses: 368866000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 8820060000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 16802759000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 7613534000.00
RPRX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 209799000.00
RPRX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -59973000.00
RPRX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -59973000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2612000.00
RPRX balance_sheet (quarterly, 2025-06-30) — Working Capital: 313715000.00
RPRX income_statement (quarterly, 2025-09-30) — +Operating Expense: 182135000.00
RPRX income_statement (quarterly, 2025-09-30) — +Total Revenue: 609291000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 41415000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4112538000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 16195567000.00
RPRX income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 84174000.00
RPRX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 429027000.00
RPRX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.67
RPRX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 631908000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 107000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 938944000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1815117000.00
RPRX cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -95312000.00
RPRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 562735000.00
RPRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -958314000.00
RPRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 702615000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 10907000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -56565000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Interest Payable: -56565000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -3054000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1006000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Payable: 10907000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -45658000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1158000.00
RPRX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -50876000.00
RPRX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 307036000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Common Stock: 107000.00
RPRX cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -95312000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6414348000.00
RPRX cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -146493000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 29044000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Current Assets: 1849537000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Current Debt: 380000000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 380000000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 530802000.00
RPRX cash_flow (quarterly, 2025-09-30) — Depreciation: 1277000.00
RPRX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1277000.00
RPRX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1277000.00
RPRX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 560000000.00
RPRX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.51
RPRX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 372391000.00
RPRX cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 0.00
RPRX balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 77222000.00
RPRX cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 905000.00
RPRX income_statement (quarterly, 2025-09-30) — EBIT: 523775000.00
RPRX income_statement (quarterly, 2025-09-30) — EBITDA: 525052000.00
RPRX income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 15948000.00
RPRX cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -15948000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 502938000.00
RPRX cash_flow (quarterly, 2025-09-30) — End Cash Position: 938944000.00
RPRX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 562735000.00
RPRX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 702615000.00
RPRX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -654155000.00
RPRX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 75343000.00
RPRX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 118734000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Goodwill: 924634000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 924634000.00
RPRX income_statement (quarterly, 2025-09-30) — Interest Expense: 79564000.00
RPRX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 79564000.00
RPRX income_statement (quarterly, 2025-09-30) — Interest Income: 6903000.00
RPRX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 6903000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Interest Payable: 29044000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 15360083000.00
RPRX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -958314000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 16195567000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 16486524000.00
RPRX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 3229475000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 8565735000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 8565735000.00
RPRX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 3229475000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 290957000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Minority Interest: 3206513000.00
RPRX income_statement (quarterly, 2025-09-30) — Minority Interests: -155994000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -226000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -146493000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Net Debt: 8006791000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Income: 288217000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 288217000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 444211000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 288217000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 288217000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 444211000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 444211000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Interest Income: -72661000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -958993000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 954475000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 954475000.00
RPRX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -72661000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -149935000.00
RPRX cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
RPRX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5489714000.00
RPRX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 449709000.00
RPRX income_statement (quarterly, 2025-09-30) — Normalized Income: 212874000.00
RPRX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 702615000.00
RPRX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -670103000.00
RPRX income_statement (quarterly, 2025-09-30) — Operating Income: 427156000.00
RPRX income_statement (quarterly, 2025-09-30) — Operating Revenue: 609291000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 429027000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5519000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 3121000.00
RPRX income_statement (quarterly, 2025-09-30) — Other Gand A: 45381000.00
RPRX income_statement (quarterly, 2025-09-30) — Other Income Expense: 89716000.00
RPRX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 892363000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 86585000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 126944000.00
RPRX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1575000.00
RPRX income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 12135000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 28901000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 876173000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Payables: 118637000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 147681000.00
RPRX income_statement (quarterly, 2025-09-30) — Pretax Income: 444211000.00
RPRX income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 766000.00
RPRX cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 12901000.00
RPRX cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -226000.00
RPRX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -961873000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Receivables: 28901000.00
RPRX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1277000.00
RPRX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -146493000.00
RPRX income_statement (quarterly, 2025-09-30) — Research And Development: 50500000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2304314000.00
RPRX income_statement (quarterly, 2025-09-30) — Salaries And Wages: 73353000.00
RPRX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 2880000.00
RPRX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 118734000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Share Issued: 429027000.00
RPRX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 72842000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6414348000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 5489714000.00
RPRX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
RPRX income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
RPRX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
RPRX balance_sheet (quarterly, 2025-09-30) — Total Assets: 19347280000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 14980083000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Total Debt: 8945735000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9620861000.00
RPRX income_statement (quarterly, 2025-09-30) — Total Expenses: 182135000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 9726419000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 17497743000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 9195617000.00
RPRX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 427156000.00
RPRX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 75343000.00
RPRX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 75343000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 2611000.00
RPRX balance_sheet (quarterly, 2025-09-30) — Working Capital: 1318735000.00
RPRX income_statement (annual, 2025-12-31) — +Operating Expense: 818675000.00
RPRX income_statement (quarterly, 2025-12-31) — +Operating Expense: 233608000.00
RPRX income_statement (annual, 2025-12-31) — +Total Revenue: 2378193000.00
RPRX income_statement (quarterly, 2025-12-31) — +Total Revenue: 621990000.00
RPRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 19404000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 19404000.00
RPRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4123088000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4123088000.00
RPRX balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 16798794000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 16798794000.00
RPRX income_statement (annual, 2025-12-31) — Average Dilution Earnings: 234575000.00
RPRX income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 63909000.00
RPRX income_statement (annual, 2025-12-31) — Basic Average Shares: 428669000.00
RPRX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 428669000.00
RPRX income_statement (annual, 2025-12-31) — Basic EPS: 1.80
RPRX income_statement (quarterly, 2025-12-31) — Basic EPS: 0.50
RPRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 929026000.00
RPRX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 938944000.00
RPRX balance_sheet (annual, 2025-12-31) — Capital Stock: 106000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 106000.00
RPRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 618696000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 618696000.00
RPRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1491882000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1491882000.00
RPRX cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -378253000.00
RPRX cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -94343000.00
RPRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1185973000.00
RPRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -299595000.00
RPRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1614180000.00
RPRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -847801000.00
RPRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2489823000.00
RPRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 827148000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Account Payable: -13928000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -28532000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 8934000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 81774000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Interest Payable: 8934000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Interest Payable: 81774000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -7447000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -3307000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -2350000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1012000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Payable: -13928000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Payable: -28532000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -4994000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 53242000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Receivables: -2360000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -415000.00
RPRX cash_flow (annual, 2025-12-31) — Change In Working Capital: -17151000.00
RPRX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 48508000.00
RPRX cash_flow (annual, 2025-12-31) — Changes In Cash: -310330000.00
RPRX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -320248000.00
RPRX balance_sheet (annual, 2025-12-31) — Common Stock: 106000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 106000.00
RPRX cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -378253000.00
RPRX cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -94343000.00
RPRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6476900000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6476900000.00
RPRX cash_flow (annual, 2025-12-31) — Common Stock Payments: -1227383000.00
RPRX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -80537000.00
RPRX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 110818000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 110818000.00
RPRX balance_sheet (annual, 2025-12-31) — Current Assets: 1528091000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Current Assets: 1528091000.00
RPRX balance_sheet (annual, 2025-12-31) — Current Debt: 380000000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Current Debt: 380000000.00
RPRX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 380000000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 380000000.00
RPRX balance_sheet (annual, 2025-12-31) — Current Liabilities: 636211000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 636211000.00
RPRX cash_flow (annual, 2025-12-31) — Depreciation: 3852000.00
RPRX cash_flow (quarterly, 2025-12-31) — Depreciation: 1196000.00
RPRX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3852000.00
RPRX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1196000.00
RPRX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3852000.00
RPRX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1196000.00
RPRX income_statement (annual, 2025-12-31) — Diluted Average Shares: 564000000.00
RPRX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 556000000.00
RPRX income_statement (annual, 2025-12-31) — Diluted EPS: 1.37
RPRX income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.38
RPRX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1005522000.00
RPRX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 278114000.00
RPRX cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 13396000.00
RPRX cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 0.00
RPRX balance_sheet (annual, 2025-12-31) — Dividends Payable: 72825000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 72825000.00
RPRX cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 105149000.00
RPRX cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 4994000.00
RPRX income_statement (annual, 2025-12-31) — EBIT: 1631856000.00
RPRX income_statement (quarterly, 2025-12-31) — EBIT: 450084000.00
RPRX income_statement (annual, 2025-12-31) — EBITDA: 1635708000.00
RPRX income_statement (quarterly, 2025-12-31) — EBITDA: 451280000.00
RPRX income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 29089000.00
RPRX income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 4005000.00
RPRX cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -29089000.00
RPRX cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -4005000.00
RPRX balance_sheet (annual, 2025-12-31) — Employee Benefits: 577870000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 577870000.00
RPRX cash_flow (annual, 2025-12-31) — End Cash Position: 618696000.00
RPRX cash_flow (quarterly, 2025-12-31) — End Cash Position: 618696000.00
RPRX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1185973000.00
RPRX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -299595000.00
RPRX cash_flow (annual, 2025-12-31) — Free Cash Flow: 2489823000.00
RPRX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 827148000.00
RPRX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -2285159000.00
RPRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -651228000.00
RPRX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 24007000.00
RPRX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 58796000.00
RPRX income_statement (annual, 2025-12-31) — General And Administrative Expense: 573481000.00
RPRX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 164272000.00
RPRX balance_sheet (annual, 2025-12-31) — Goodwill: 924634000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Goodwill: 924634000.00
RPRX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 924634000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 924634000.00
RPRX income_statement (annual, 2025-12-31) — Interest Expense: 307664000.00
RPRX income_statement (quarterly, 2025-12-31) — Interest Expense: 94171000.00
RPRX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 307664000.00
RPRX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 94171000.00
RPRX income_statement (annual, 2025-12-31) — Interest Income: 33591000.00
RPRX income_statement (quarterly, 2025-12-31) — Interest Income: 7071000.00
RPRX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 33591000.00
RPRX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 7071000.00
RPRX balance_sheet (annual, 2025-12-31) — Interest Payable: 110818000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Interest Payable: 110818000.00
RPRX balance_sheet (annual, 2025-12-31) — Invested Capital: 15427817000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 15427817000.00
RPRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1614180000.00
RPRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -847801000.00
RPRX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 16798794000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 16798794000.00
RPRX balance_sheet (annual, 2025-12-31) — Investments And Advances: 17088762000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 17088762000.00
RPRX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3229475000.00
RPRX cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
RPRX balance_sheet (annual, 2025-12-31) — Long Term Debt: 8570917000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 8570917000.00
RPRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8570917000.00
RPRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8570917000.00
RPRX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3229475000.00
RPRX cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
RPRX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2275000000.00
RPRX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
RPRX balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 289968000.00